# Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

> **NCT03159845** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliero, Universitaria Pisana** · enrollment: 20 (estimated)

## Conditions studied

- Stem Cell Transplant Complications

## Interventions

- **DRUG:** Zinc Sulfate Oral Product
- **DRUG:** Levofloxacin 500Mg Oral Tablet
- **DRUG:** Fluconazole 200mg tab
- **DRUG:** Acyclovir 400 MG

## Key facts

- **NCT ID:** NCT03159845
- **Lead sponsor:** Azienda Ospedaliero, Universitaria Pisana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2019-09-10
- **Final completion:** 2019-09-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159845, "Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03159845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*